AutoAntiBody


Programme

Accelerate

Sector

Healthcare/Pharma/Biotech


Autoimmunity contributes to many diseases. Chronic fatigue syndrome, Long COVID, lupus, arthritis, cancer – the list is long. Emerging science suggests that autoantibodies that activate or inhibit G protein coupled receptors (functional antibodies) in a large number of diseases. The presence of such autoantibodies can be used for a diagnostic blood test.

Our company AAB (AutoAntiBody) Research is developing technology to detect and identify functional autoantibodies against membrane receptors for diagnostic and therapeutic purposes. We are aiming to initially develop diagnostic tests for chronic fatigue syndrome (1% of the population) and then extend to other diseases with AAB against GPCRs.

Top